Postoperative Adjuvant Chemotherapy for Descending Colon Cancer Treated with Imatinib for Chronic Myeloid Leukemia

A66 -year-old man was diagnosed with chronic myeloid leukemia(CML). Imatinib treatment had been initiated, and a major molecular response(MMR)was achieved. The patient had anemia and was diagnosed with descending colon cancer. The patient was surgically treated, and then received postoperative adjuv...

Full description

Saved in:
Bibliographic Details
Published inGan to kagaku ryoho Vol. 46; no. 8; p. 1319
Main Authors Tatsuta, Kyota, Harada, Takashi, Miyazaki, Shinichiro, Ogiku, Masahito, Hayashi, Tadataka, Tamura, Hiroaki, Kanai, Toshikazu, Ikematsu, Yoshito, Naito, Kensuke, Nishiwaki, Yoshiro
Format Journal Article
LanguageJapanese
Published Japan 01.08.2019
Subjects
Aged
Antineoplastic Agents
Chemotherapy, Adjuvant
Colon, Descending
Colonic Neoplasms - drug therapy
Colonic Neoplasms - surgery
Humans
Imatinib Mesylate
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy
Leukemia, Myelogenous, Chronic, BCR-ABL Positive - surgery
Male
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:A66 -year-old man was diagnosed with chronic myeloid leukemia(CML). Imatinib treatment had been initiated, and a major molecular response(MMR)was achieved. The patient had anemia and was diagnosed with descending colon cancer. The patient was surgically treated, and then received postoperative adjuvant chemotherapy with UFT/LV. However, imatinib was not administered during that period. The patient could undergo postoperative adjuvant chemotherapy for 6 months without acute exacerbation of the CML.
ISSN:0385-0684